Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
UCARTCS1A for Multiple Myeloma
Recruiting1 awardPhase 1
Rochester, Minnesota
This trial is testing a new treatment called UCARTCS1A, which uses modified immune cells to target and kill cancer cells. It is aimed at patients with multiple myeloma that has come back or didn't respond to other treatments. The goal is to see if this treatment is safe and effective. UCARTCS1A is a type of CAR-T cell therapy, which is a promising approach in treating multiple myeloma by using modified immune cells to target cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service